Trials / Not Yet Recruiting
Not Yet RecruitingNCT06511609
The Anti-reflux Effect of Double-flap Technique in Laparoscopic Proximal Gastrectomy.
Comparison of Anti-reflux Effects of Laparoscopic Proximal Gastrectomy With Double-flap Technique (Kamikawa Anastomosis) Versus Double-tract Reconstruction: A Prospective, Multicenter, Randomized Controlled Trial.
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 244 (estimated)
- Sponsor
- Changzhi People's Hospital Affiliated to Changzhi Medical College · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, open-label, prospective, randomized parallel-controlled trial. The purpose is to explore whether the incidence rate of reflux esophagitis (RE) within 12 months after surgery is non-inferior for the DFT group compared to the DTR group.
Detailed description
This study will enroll patients with proximal gastric cancer scheduled to undergo laparoscopic proximal gastrectomy. The patients will be randomly divided into two groups. One group will undergo laparoscopic proximal gastrectomy with double-flap technique (DFT) anastomosis, while the other group will undergo laparoscopic proximal gastrectomy with double-tract reconstruction (DTR). The primary endpoint is the proportion of patients who develop reflux esophagitis within 12 months after surgery. The secondary endpoints include postoperative complications, surgery-related indicators, and postoperative nutritional status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | double-flap technique(DFT); double-tract reconstruction(DTR), | DFT (experiment group). Patients receive double flap technique after laparoscopic proximal gastrectomy. DTR (control group). Patients receive double-tract reconstruction after laparoscopic proximal gastrectomy. |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2026-07-31
- Completion
- 2027-07-31
- First posted
- 2024-07-22
- Last updated
- 2024-07-22
Source: ClinicalTrials.gov record NCT06511609. Inclusion in this directory is not an endorsement.